Skip to main content
OpenTrials
Completed

NCT Number: NCT02982408

Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes

Low birth weight (LBW), a marker of impaired fetal growth is an independent and strong risk factor for type 2 diabetes (T2D). A western lifestyle characterized by a surplus of calories, and/or a low physical activity level, associated with increased fat storage and altered lipid metabolism plays a central role in the pathogenesis of insulin resistance and T2D. Using state-of-the-art large-scale integrative physiology studies combined with basic studies of adipose and muscle tissue stem cell functions, the investigators aim to determine if LBW individuals exhibit decreased subcutaneous adipose tissue expandability, postprandial hyperlipidaemia and ectopic fat accumulation when exposed to 4 weeks of carbohydrate overfeeding. The investigators will subsequently examine if exercise training can revert and/or minimize the deleterious effects of carbohydrate overfeeding in a possibly birth weight differential manner.

Completed

Looking for future studies?

Notify Me

Key information

Age range

35 year–40 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Rigshospitalet, Denmark

Copenhagen, Capital Region, 2100, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • without known disease (approved health examination)
  • caucasian
  • born at term (weeks 39-41) in Denmark
  • recruited from the national Danish Birth Registry
  • born with either low or normal birthweight (see previous)

Exclusion criteria

  • family history of diabetes in two generations (1st and 2nd degree relatives)
  • self-reported high physical activity level (>10hrs /week).
  • weight loss/gain >3 kg within the past 6 months
  • alcohol intake of more than general recommendations
  • substance abuser
  • intake of medication know to affect outcomes

Treatment and study plan

High carbohydrate overfeeding

Dietary Supplement

All participant's individual energy requirement will be determined in mega joules (MJ) per day. The energy requirement will be multiplied by a factor 1.5 for a low physical activity level (PAL). The MJ will be rounded up or down to the nearest whole number.

The participant will receive food corresponding to ~25% additional energy above their calculated energy requirement. The 25% extra energy will be supplied to the participants for 4 weeks in the form of food containing simple carbohydrates. The subjects will be given a daily snack package containing processed foods or refined foods such as sweets, cookies, soft drinks, juice etc. To ensure an adequate energy surplus (i.e. weight gain), physical activity has to be decreased to a low level during the 4 weeks overfeeding period.

Exercise

Behavioral

Half of the participants will be randomized to a 3-month exercise-training program.

The training program consists of combined aerobic training and strength training. The training program is performed unsupervised 3 times per week 45 minutes per session for 3 months in the local fitness center. Before engaging in the training program a maximal oxygen consumption test (VO2 max) are conducted and the maximal heartrate (HR) are determined.Participants are wearing the Polar V800 HR monitor and are asked to note their HR in a training log at the end of the last interval at each training session. The strength training program consist of 6 exercises (2 exercises paired together) involving the large muscle groups. The first training session is completed supervised at Rigshospitalet . After 6 weeks the training program is adjusted. Compliance will be ensured by phone calls, text messages and e-mails from study personnel.

Normal physical activity

Behavioral

The other half of the participants will be randomized to a 3-month with normal physical activity level (control).

The participants will have to return to the physical activity level they had before entering the study (baseline level). Compliance will be ensured by phone calls and text messages from study personnel. The subjects will wear a simple pedometer on the hip showing the number of steps. Once a week a text message (SMS-track) is automatically sent asking the participants to enter the weekly number of steps. The test personnel receive the reply and contact the participant if the number of steps does not match the baseline level. During the first and the last 7 days of the exercise intervention participants are wearing 2 accelerometers measuring their physical activity behavior.

Primary outcomes

  1. Adipose tissue expandability

    Time frame: baseline

    Percent (%) subcutaneous, visceral adipose tissue and hepatic fat will be determined by MR scanning in the two groups

  2. Adipose tissue expandability

    Time frame: Difference between the two groups at baseline, after 4 weeks overfeeding and after 12 weeks exercise training.

    Percent (%) subcutaneous, visceral adipose tissue and hepatic fat will be determined by MR scanning in the two groups

Secondary outcomes

  1. Glucose turnover rate

    Time frame: Baseline, 4 weeks overfeeding, 12 weeks training

    Turnover rates will be measured after a 5 hr mealtest by use isotopic tracers in the two groups

  2. Lipid turnover rate

    Time frame: Baseline, 4 weeks overfeeding, 12 weeks training

    Turnover rates will be measured after a 5 hr mealtest by use isotopic tracers in the two groups

  3. Epigenetics

    Time frame: Baseline, 4 weeks overfeeding, 12 weeks training

    Marks of adipose tissue, skeletal muscle stem cell and differentiated cell type genomes.

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Collaborators

  • Augustinus Fonden
  • Novo Nordisk A/S

Registry information

Official study title

Can Exercise Training Revert and/or Minimize the Deleterious Cardiometabolic Effects of Carbohydrate Overfeeding in Individuals With and Without Increased Risk of Type 2 Diabetes?

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Dec 5, 2016
Registry last updated
Sep 6, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.